Among older adults, serum 25-OHD <15 ng/ml was associated with a 29% greater risk of mortality (95% CI 1.05-1.55), and PTH ≥65 pg/ml was associated with a 30% greater risk of heart failure.
Cohort (n=2,312)
Effect estimate: HR 1.29 (95% CI 1.05-1.55)
OBJECTIVES: The aim of this study was to evaluate associations of 25-hydroxyvitamin D (25-OHD) and parathyroid hormone (PTH) concentrations separately and in combination with incident cardiovascular events and mortality during 14 years of follow-up in the CHS (Cardiovascular Health Study). BACKGROUND: Vitamin D deficiency and PTH excess are common in older adults and may adversely affect cardiovascular health. METHODS: A total of 2,312 participants who were free of cardiovascular disease at baseline were studied. Vitamin D and intact PTH were measured from previously frozen serum using mass spectrometry and a 2-site immunoassay. Outcomes were adjudicated cases of myocardial infarction, heart failure, cardiovascular death, and all-cause mortality. RESULTS: There were 384 participants (17%) with serum 25-OHD concentrations <15 ng/ml and 570 (25%) with serum PTH concentrations ≥ 65 pg/ml. After adjustment, each 10 ng/ml lower 25-OHD concentration was associated with a 9% greater (95% confidence interval CI: 2% to 17% greater) relative hazard of mortality and a 25% greater (95% CI: 8% to 44% greater) relative hazard of myocardial infarction. Serum 25-OHD concentrations <15 ng/ml were associated with a 29% greater (95% CI: 5% to 55% greater) risk for mortality. Serum PTH concentrations ≥ 65 pg/ml were associated with a 30% greater risk for heart failure (95% CI: 6% to 61% greater) but not other outcomes. There was no evidence of an interaction between serum 25-OHD and PTH concentrations and cardiovascular events. CONCLUSIONS: Among older adults, 25-OHD deficiency is associated with myocardial infarction and mortality; PTH excess is associated with heart failure. Vitamin D and PTH might influence cardiovascular risk through divergent pathways.
Kestenbaum et al. (Thu,) conducted a cohort in Free of cardiovascular disease at baseline (n=2,312). 25-hydroxyvitamin D (25-OHD) and parathyroid hormone (PTH) concentrations vs. Higher 25-OHD and lower PTH concentrations was evaluated on Incident cardiovascular events (myocardial infarction, heart failure, cardiovascular death) and all-cause mortality (HR 1.29, 95% CI 1.05-1.55). Among older adults, serum 25-OHD <15 ng/ml was associated with a 29% greater risk of mortality (95% CI 1.05-1.55), and PTH ≥65 pg/ml was associated with a 30% greater risk of heart failure.